This is a double blind randomized trial to evaluate effects of intravenous paracetamol on postoperative pain control.Inclusion criteria are ASA I,II patients,age between 20 to 50 years old, elective laparotomy surgeries not more than 3h ,without any history of opium addiction, prolonged analgesic or sedative consumption, cardiac, pulmonary, thyroid or hepatic dysfunction,and allergy to morphine and paracetamol. exclusion criteria are serious disgusting complications such as nausea, vomiting or itching, no patient satisfaction of analgesic protocol and need to inject analgesic more than usual or severe hepatic or respiratory complications. total sample size is 112 . the trial intervention considered is intravenous infusion of morphine and paracetamol for postoperative pain management and the pain after surgery will be measured in different times . Nausea, vomiting and itching are secondary outcomes. recruitment duration time is about 18 months.